Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

The role of CCN4/WISP-1 in the cancerous phenotype.

Nivison MP, Meier KE.

Cancer Manag Res. 2018 Aug 27;10:2893-2903. doi: 10.2147/CMAR.S133915. eCollection 2018. Review.

2.

Omega-3 Fatty Acids and Prostate Cancer: G Protein-Coupled Receptors to the Rescue.

Meier KE.

J Natl Cancer Inst. 2019 Jan 1;111(1):3-4. doi: 10.1093/jnci/djy127. No abstract available.

PMID:
30202928
3.

Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cells.

Hopkins MM, Meier KE.

Prostaglandins Leukot Essent Fatty Acids. 2017 Jul;122:24-29. doi: 10.1016/j.plefa.2017.06.013. Epub 2017 Jul 1.

PMID:
28735625
4.

Editor's Note.

Meier KE.

Mol Pharmacol. 2017 Jan;91(1):74. doi: 10.1124/mol.116.107961. Epub 2016 Dec 22. No abstract available.

PMID:
28007898
5.

Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.

Chahal MS, Ku HT, Zhang Z, Legaspi CM, Luo A, Hopkins MM, Meier KE.

Cancer Genomics Proteomics. 2016 11-12;13(6):437-442.

6.

Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.

Hopkins MM, Meier KE.

Handb Exp Pharmacol. 2017;236:233-251. doi: 10.1007/164_2016_48. Review.

PMID:
27757756
7.

Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells.

Hopkins MM, Liu Z, Meier KE.

J Pharmacol Exp Ther. 2016 Oct;359(1):124-33. doi: 10.1124/jpet.116.233379. Epub 2016 Jul 29.

8.
9.

Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.

Liu Z, Hopkins MM, Zhang Z, Quisenberry CB, Fix LC, Galvan BM, Meier KE.

J Pharmacol Exp Ther. 2015 Feb;352(2):380-94. doi: 10.1124/jpet.114.218974. Epub 2014 Dec 9.

10.

Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.

Park JJ, Rubio MV, Zhang Z, Um T, Xie Y, Knoepp SM, Snider AJ, Gibbs TC, Meier KE.

Prostate. 2012 Nov;72(15):1595-610. doi: 10.1002/pros.22513. Epub 2012 Apr 2.

PMID:
22473839
11.

Arrestins as signaling modulators: the plot thickens: focus on "Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle".

Meier KE.

Am J Physiol Cell Physiol. 2012 Mar 1;302(5):C721-2. doi: 10.1152/ajpcell.00444.2011. Epub 2011 Dec 21. No abstract available.

12.

Control of neurite outgrowth by RhoA inactivation.

Jeon CY, Moon MY, Kim JH, Kim HJ, Kim JG, Li Y, Jin JK, Kim PH, Kim HC, Meier KE, Kim YS, Park JB.

J Neurochem. 2012 Mar;120(5):684-98. doi: 10.1111/j.1471-4159.2011.07564.x. Epub 2011 Nov 24.

13.

Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines.

Zhang Z, Knoepp SM, Ku H, Sansbury HM, Xie Y, Chahal MS, Tomlinson S, Meier KE.

Clin Exp Metastasis. 2011 Aug;28(6):551-65. doi: 10.1007/s10585-011-9391-y. Epub 2011 May 1.

14.

Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells.

Chahal MS, Brauner DJ, Meier KE.

Pharmaceuticals (Basel). 2010 Jul 2;3(7):2045-2058.

15.

Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation.

Snider AJ, Zhang Z, Xie Y, Meier KE.

Am J Physiol Cell Physiol. 2010 Jan;298(1):C163-70. doi: 10.1152/ajpcell.00001.2009. Epub 2009 Oct 28.

16.

Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.

Gibbs TC, Rubio MV, Zhang Z, Xie Y, Kipp KR, Meier KE.

Prostate. 2009 Oct 1;69(14):1493-506. doi: 10.1002/pros.20994. Erratum in: Prostate. 2014 Nov;74(15):1576-8.

PMID:
19536794
17.

Integrated modulation of phorbol ester-induced Raf activation in EL4 lymphoma cells.

Han S, Meier KE.

Cell Signal. 2009 May;21(5):793-800. Epub 2009 Jan 19.

18.

Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.

Knoepp SM, Chahal MS, Xie Y, Zhang Z, Brauner DJ, Hallman MA, Robinson SA, Han S, Imai M, Tomlinson S, Meier KE.

Mol Pharmacol. 2008 Sep;74(3):574-84. doi: 10.1124/mol.107.040105. Epub 2008 Jun 3.

PMID:
18523140
19.

RasGRP1 confers the phorbol ester-sensitive phenotype to EL4 lymphoma cells.

Han S, Knoepp SM, Hallman MA, Meier KE.

Mol Pharmacol. 2007 Jan;71(1):314-22. Epub 2006 Oct 25.

PMID:
17065239
20.

Supplemental Content

Loading ...
Support Center